EUVIMEDEUVIMED entdecken
CrossrefInfokarte

Cannabis‐based products for medicinal use in dogs and cats: a systematic review

N. Moreno‐López, C. Moreno‐López, P. Amariles

Journal of Small Animal Practice · 2025-12 · 66 (12) · 855-870

DOI: 10.1111/jsap.13913 ↗
AbstractBibliografische Angaben

Abstract

Objectives Cannabis‐based products for medicinal use, also referred to as cannabinoid‐containing products, particularly those containing cannabidiol as the primary active constituent, have shown to be a possible alternative in treating various health conditions in companion animals. Thus, this systematic review aims to synthesise and analyse the available data on the efficacy/effectiveness and safety of cannabis‐based products for medicinal use in dogs and cats to assist in clinical decision‐making. Materials and Methods A systematic review was conducted across PubMed, LILACS, Scopus, and Google Scholar from February 2014 to February 2024. The search strategy included both MeSH terms and free‐text keywords related to medical cannabis, including Medical Marijuana, Cannabis and Cannabaceae, combined with terms referring to domestic cats and dogs. Additionally, title/abstract keywords, including Cannab (as a truncated term), were used to retrieve literature on cannabinoids and their therapeutic applications. Results Twenty‐two articles were identified examining cannabidiol‐based formulations for osteoarthritis, epilepsy, atopic dermatitis, postsurgical pain, and behavioural issues. Cannabis‐based products for medicinal use with cannabidiol as the primary active constituent demonstrated improvements in pain, behaviour, and seizures, with no serious adverse events. However, research on their use in cats is limited to two studies. Clinical Significance While promising, the long‐term efficacy/effectiveness, optimal dosages, and safety of cannabis‐based products for medicinal use remain unclear. Further studies are needed to confirm their therapeutic potential and ensure safe veterinary use.

Wissen, das zu Ihrer Arbeit passt.

Vom kostenlosen Einstieg über die persönliche Recherche bis zur vollständigen Research Suite.

Tarife ansehen →

Sind alle Verlagsvolltexte enthalten?

Nein. Bibliografische Nachweise, Abstracts und Volltexte sind unterschiedliche Inhalte. Ob ein Volltext verfügbar ist, hängt von der Quelle, Open Access und Ihren vorhandenen Lizenzen ab. Ein EUVIMED-Tarif ersetzt keine zusätzlichen Verlagsrechte.

Tarife ansehen →